Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

Having an mRNA COVID vaccine will not make your body produce new tumour-fighting T cells. What it might do, based on this ...

COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

In the wake of the COVID-19 pandemic, messenger RNA (mRNA) vaccines reshaped how scientists design and deliver immunizations. But researchers are still working to make them more potent, longer-lasting ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of Long COVID. The study shows that the SARS-CoV-2 ...